Background on AG Program

On May 13, 2004, Warner-Lambert, a division of Pfizer, Inc., entered into an Assurance of Voluntary Compliance/Discontinuance with the Attorneys General of 50 States and the District of Columbia to settle allegations that Warner-Lambert conducted an unlawful marketing campaign for the drug Neurontin® that violated state consumer protection laws. Among other things, the settlement provides for a $21 million Consumer and Prescriber Education grant program to be administered by a Special Committee of State Attorneys General pursuant to an Oregon Court Order and an Attorney General Memorandum of Understanding.

The Attorney General Consumer and Prescriber Education Grant Program will fund programs designed to provide health care professionals and consumers information relating to prescription drugs, including the way in which drugs are marketed. Grants will be made in several rounds. The first rounds focused on prescriber education. The next round will focus on consumer education.